{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:37:08Z","timestamp":1785685028558,"version":"3.56.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,1,23]],"date-time":"2007-01-23T00:00:00Z","timestamp":1169510400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1038\/sj.bjc.6603585","type":"journal-article","created":{"date-parts":[[2007,1,23]],"date-time":"2007-01-23T13:47:31Z","timestamp":1169560051000},"page":"432-438","source":"Crossref","is-referenced-by-count":34,"title":["Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer"],"prefix":"10.1038","volume":"96","author":[{"given":"V","family":"Chiarion-Sileni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ruol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Innocente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Boso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Del Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Pigozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Mazzarotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Tomassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Ancona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,23]]},"reference":[{"key":"BF6603585_CR1","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1200\/JCO.2000.18.10.2032","volume":"18","author":"DJ Adelstein","year":"2000","unstructured":"Adelstein DJ, Rice TW, Rybicki LA, Larto MA, Ciezki J, Saxton J, DeCamp M, Vargo JJ, Dumot JA, Zuccaro G (2000) Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy. J Clin Oncol 18: 2032\u20132039","journal-title":"J Clin Oncol"},{"key":"BF6603585_CR2","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1093\/jnci\/86.14.1086","volume":"86","author":"JA Ajani","year":"1994","unstructured":"Ajani JA, Ilson DH, Daugherty K, Pazdur R, Lynch PM, Kelsen DP (1994) Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 86: 1086\u20131091","journal-title":"J Natl Cancer Inst"},{"key":"BF6603585_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1200\/JCO.1997.15.1.277","volume":"15","author":"M al-Sarraf","year":"1997","unstructured":"al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, Cooper J, Byhardt R, Davis L, Emami B (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15: 277\u2013284","journal-title":"J Clin Oncol"},{"key":"BF6603585_CR4","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1002\/1097-0142(20010601)91:11<2165::AID-CNCR1245>3.0.CO;2-H","volume":"91","author":"E Ancona","year":"2001","unstructured":"Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, Zaninotto G, Bonavina L, Peracchia A (2001) Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 91: 2165\u20132174","journal-title":"Cancer"},{"key":"BF6603585_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2307\/2531294","volume":"41","author":"EN Atkinson","year":"1985","unstructured":"Atkinson EN, Brown BW (1985) Confidence limits for probability of response in multistage phase II clinical trials. Biometrics 41: 741\u2013744","journal-title":"Biometrics"},{"key":"BF6603585_CR6","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/S0959-8049(97)00088-9","volume":"33","author":"H Bleiberg","year":"1997","unstructured":"Bleiberg H, Conroy T, Paillot B, Lacave AJ, Blijham G, Jacob JH, Bedenne L, Namer M, De Besi P, Gay F, Collette L, Sahmoud T (1997) Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer 33: 1216\u20131220","journal-title":"Eur J Cancer"},{"key":"BF6603585_CR7","first-page":"2","volume":"26","author":"WJ Blot","year":"1999","unstructured":"Blot WJ, McLaughlin JK (1999) The changing epidemiology of esophageal cancer. Semin Oncol 26: 2\u20138","journal-title":"Semin Oncol"},{"key":"BF6603585_CR8","first-page":"137","volume":"11","author":"H Burris","year":"1992","unstructured":"Burris H, Irvin R, Kuhn J, Kalter S, Smith L, Shaffer D, Rodriguez G, Weiss G, Eckardt J, Vreeland F, Baysass M, Von Hoff D (1992) A phase I clinical trial of taxotere as a 6\u2009h infusion repeated every 21 days in patients with refractory solid tumors [abstract]. Proc Am Soc Clin Oncol 11: 137","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6603585_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/oxfordjournals.annonc.a058908","volume":"5","author":"G Catimel","year":"1994","unstructured":"Catimel G, Verweij J, Mattijssen V, Hanauske A, Piccart M, Wanders J, Franklin H, Le Bail N, Clavel M, Kaye SB (1994) Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group. Ann Oncol 5: 533\u2013537","journal-title":"Ann Oncol"},{"key":"BF6603585_CR10","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1200\/JCO.1998.16.4.1331","volume":"16","author":"AD Colevas","year":"1998","unstructured":"Colevas AD, Busse PM, Norris CM, Fried M, Tishler RB, Poulin M, Fabian RL, Fitzgerald TJ, Dreyfuss A, Peters ES, Adak S, Costello R, Barton JJ, Posner MR (1998) Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I\/II trial. J Clin Oncol 16: 1331\u20131339","journal-title":"J Clin Oncol"},{"key":"BF6603585_CR11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/annonc\/mdf063","volume":"13","author":"T Conroy","year":"2002","unstructured":"Conroy T, Etienne PL, Adenis A, Ducreux M, Paillot B, Oliveira J, Seitz JF, Francois E, Van Cutsem E, Wagener DJ, Kohser F, Daamen S, Praet M, Gorlia T, Baron B, Wils J (2002) Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival. Ann Oncol 13: 721\u2013729","journal-title":"Ann Oncol"},{"key":"BF6603585_CR12","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","volume":"281","author":"JS Cooper","year":"1999","unstructured":"Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson Jr JA, Al-Sarraf M, Byhardt R, Russell AH, Beitler JJ, Spencer S, Asbell SO, Graham MV, Leichman LL (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281: 1623\u20131627","journal-title":"JAMA"},{"key":"BF6603585_CR13","first-page":"909","volume":"70","author":"P De Besi","year":"1986","unstructured":"De Besi P, Sileni VC, Salvagno L, Tremolada C, Cartei G, Fosser V, Paccagnella A, Peracchia A, Fiorentino M (1986) Phase II study of cisplatin, 5-FU, and allopurinol in advanced esophageal cancer. Cancer Treat Rep 70: 909\u2013910","journal-title":"Cancer Treat Rep"},{"key":"BF6603585_CR14","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1200\/JCO.1996.14.5.1672","volume":"14","author":"AI Dreyfuss","year":"1996","unstructured":"Dreyfuss AI, Clark JR, Norris CM, Rossi RM, Lucarini JW, Busse PM, Poulin MD, Thornhill L, Costello R, Posner MR (1996) Docetaxel: an active drug for squamous cell carcinoma of the head and neck. J Clin Oncol 14: 1672\u20131678","journal-title":"J Clin Oncol"},{"key":"BF6603585_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF02993858","volume":"13","author":"AI Einzig","year":"1996","unstructured":"Einzig AI, Neuberg D, Remick SC, Karp DD, O'Dwyer PJ, Stewart JA, Benson III AB (1996) Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293. Med Oncol 13: 87\u201393","journal-title":"Med Oncol"},{"key":"BF6603585_CR16","first-page":"12","volume":"26","author":"PC Enzinger","year":"1999","unstructured":"Enzinger PC, Ilson DH, Kelsen DP (1999) Chemotherapy in esophageal cancer. Semin Oncol 26: 12\u201320","journal-title":"Semin Oncol"},{"key":"BF6603585_CR17","volume-title":"AJCC Cancer Staging Manual","author":"IE Fleming","year":"1997","unstructured":"Fleming IE (1997) AJCC Cancer Staging Manual. Philadelphia, PA: Lippincot-Raven."},{"key":"BF6603585_CR18","doi-asserted-by":"publisher","first-page":"195S","DOI":"10.1378\/chest.112.4_Supplement.195S","volume":"112","author":"AA Forastiere","year":"1997","unstructured":"Forastiere AA, Heitmiller RF, Kleinberg L (1997) Multimodality therapy for esophageal cancer. Chest 112: 195S\u2013200S","journal-title":"Chest"},{"key":"BF6603585_CR19","first-page":"27","volume":"17","author":"R Govindan","year":"2003","unstructured":"Govindan R, Read W, Faust J, Trinkaus K, Ma MK, Baker SD, McLeod HL, Perry MC (2003) Phase II study of docetaxel and irinotecan in metastatic or recurrent esophageal cancer: a preliminary report. Oncology (Williston Park) 17: 27\u201331","journal-title":"Oncology (Williston Park)"},{"key":"BF6603585_CR20","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/bjc.1995.522","volume":"72","author":"HJ Groen","year":"1995","unstructured":"Groen HJ, Sleijfer S, Meijer C, Kampinga HH, Konings AW, De Vries EG, Mulder NH (1995a) Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines. Br J Cancer 72: 1406\u20131411","journal-title":"Br J Cancer"},{"key":"BF6603585_CR21","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/bjc.1995.448","volume":"72","author":"HJ Groen","year":"1995","unstructured":"Groen HJ, van der Leest AH, de Vries EG, Uges DR, Szabo BG, Mulder NH (1995b) Continuous carboplatin infusion during 6 weeks' radiotherapy in locally inoperable non-small-cell lung cancer: a phase I and pharmacokinetic study. Br J Cancer 72: 992\u2013997","journal-title":"Br J Cancer"},{"key":"BF6603585_CR22","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1200\/JCO.1990.8.12.1935","volume":"8","author":"WM Hryniuk","year":"1990","unstructured":"Hryniuk WM, Goodyear M (1990) The calculation of received dose intensity. J Clin Oncol 8: 1935\u20131937","journal-title":"J Clin Oncol"},{"key":"BF6603585_CR23","first-page":"22","volume":"18","author":"DH Ilson","year":"2004","unstructured":"Ilson DH (2004) Phase II trial of weekly irinotecan\/cisplatin in advanced esophageal cancer. Oncology (Williston Park) 18: 22\u201325","journal-title":"Oncology (Williston Park)"},{"key":"BF6603585_CR24","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S1055-3207(18)30300-4","volume":"6","author":"DH Ilson","year":"1997","unstructured":"Ilson DH, Bains M, Ginsberg RJ, Kelsen DP (1997) Neoadjuvant therapy of esophageal cancer. Surg Oncol Clin N Am 6: 723\u2013740","journal-title":"Surg Oncol Clin N Am"},{"key":"BF6603585_CR25","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1200\/JCO.2003.02.147","volume":"21","author":"DH Ilson","year":"2003","unstructured":"Ilson DH, Bains M, Kelsen DP, O'Reilly E, Karpeh M, Coit D, Rusch V, Gonen M, Wilson K, Minsky BD (2003) Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer. J Clin Oncol 21: 2926\u20132932","journal-title":"J Clin Oncol"},{"key":"BF6603585_CR26","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1200\/JCO.1999.17.10.3270","volume":"17","author":"DH Ilson","year":"1999","unstructured":"Ilson DH, Saltz L, Enzinger P, Huang Y, Kornblith A, Gollub M, O'Reilly E, Schwartz G, DeGroff J, Gonzalez G, Kelsen DP (1999) Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol 17: 3270\u20133275","journal-title":"J Clin Oncol"},{"key":"BF6603585_CR27","first-page":"1540","volume":"38","author":"H Kawamura","year":"1997","unstructured":"Kawamura H, Terashima M, Ikeda K, Takiyama I, Sasaki N, Ishiba K, Saito K (1997) Antitumor activities of Taxotere and Taxol against human esophageal cancer [abstract]. Proc Am Assoc Cancer Res 38: 1540","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF6603585_CR28","first-page":"S19-77","volume":"24","author":"D Kelsen","year":"1997","unstructured":"Kelsen D, Ginsberg R, Bains M, Cooper J, Arquette M, Forastiere AA, Ilson D (1997) A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: a preliminary report. Semin Oncol 24: S19-77\u2013S19-81","journal-title":"Semin Oncol"},{"key":"BF6603585_CR29","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1056\/NEJM199310283291803","volume":"329","author":"K Knyrim","year":"1993","unstructured":"Knyrim K, Wagner HJ, Bethge N, Keymling M, Vakil N (1993) A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 329: 1302\u20131307","journal-title":"N Engl J Med"},{"key":"BF6603585_CR30","first-page":"392","volume":"26","author":"T Kodaira","year":"2003","unstructured":"Kodaira T, Fuwa N, Itoh Y, Kamata M, Furutani K, Hatooka S, Shinoda M (2003) Multivariate analysis of treatment outcome in patients with esophageal carcinoma treated with definitive radiotherapy. Am J Clin Oncol 26: 392\u2013397","journal-title":"Am J Clin Oncol"},{"key":"BF6603585_CR31","first-page":"647","volume":"28","author":"E Laack","year":"2005","unstructured":"Laack E, Andritzky B, Durk H, Burkholder I, Edler L, Schuch G, Boeters I, Gorn M, Lipp R, Horst H, Popp J, Hossfeld DK (2005) Docetaxel and cisplatin as first-line treatment for patients with metastatic esophageal cancer: a pilot study. Onkologie 28: 647\u2013650","journal-title":"Onkologie"},{"key":"BF6603585_CR32","first-page":"168","volume":"31","author":"L Loreggian","year":"1997","unstructured":"Loreggian L, Chiarion Sileni V, Fede A, Friso ML, Lora O, Barbara R, Riddi F, Paccagnella A (1997) Chemo-radiotherapy in the elderly and\/or poor performance status patients with advanced head and neck cancer. Radiol Oncol 31: 168\u2013170","journal-title":"Radiol Oncol"},{"key":"BF6603585_CR33","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1038\/sj.bjc.6602645","volume":"92","author":"S Lorenzen","year":"2005","unstructured":"Lorenzen S, Duyster J, Lersch C, von Delius S, Hennig M, Bredenkamp R, Peschel C, Lordick F (2005) Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial. Br J Cancer 92: 2129\u20132133","journal-title":"Br J Cancer"},{"key":"BF6603585_CR34","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/bjs.1800770804","volume":"77","author":"JM Muller","year":"1990","unstructured":"Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H (1990) Surgical therapy of oesophageal carcinoma. Br J Surg 77: 845\u2013857","journal-title":"Br J Surg"},{"key":"BF6603585_CR35","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/annonc\/mdh231","volume":"15","author":"K Muro","year":"2004","unstructured":"Muro K, Hamaguchi T, Ohtsu A, Boku N, Chin K, Hyodo I, Fujita H, Takiyama W, Ohtsu T (2004) A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer. Ann Oncol 15: 955\u2013959","journal-title":"Ann Oncol"},{"key":"BF6603585_CR36","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1200\/JCO.1999.17.9.2915","volume":"17","author":"A Ohtsu","year":"1999","unstructured":"Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, Satake M, Ishikura S, Ogino T, Miyata Y, Seki S, Kaneko K, Nakamura A (1999) Definitive chemoradiotherapy for T4 and\/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 17: 2915\u20132921","journal-title":"J Clin Oncol"},{"key":"BF6603585_CR37","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/bjc.1998.524","volume":"78","author":"S Petrasch","year":"1998","unstructured":"Petrasch S, Welt A, Reinacher A, Graeven U, Konig M, Schmiegel W (1998) Chemotherapy with cisplatin and paclitaxel in patients with locally advanced, recurrent or metastatic oesophageal cancer. Br J Cancer 78: 511\u2013514","journal-title":"Br J Cancer"},{"key":"BF6603585_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<18::AID-IJC5>3.0.CO;2-M","volume":"83","author":"P Pisani","year":"1999","unstructured":"Pisani P, Parkin DM, Bray F, Ferlay J (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83: 18\u201329","journal-title":"Int J Cancer"},{"key":"BF6603585_CR39","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1038\/sj.bjc.6601364","volume":"89","author":"MB Polee","year":"2003","unstructured":"Polee MB, Hop WC, Kok TC, Eskens FA, van der Burg ME, Splinter TA, Siersema PD, Tilanus HW, Stoter G, van der Gaast A (2003) Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy. Br J Cancer 89: 2045\u20132050","journal-title":"Br J Cancer"},{"key":"BF6603585_CR40","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1002\/cncr.21439","volume":"104","author":"P Rohatgi","year":"2005","unstructured":"Rohatgi P, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Rice DC, Roth JA, Ajani JA (2005) Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer 104: 2365\u20132372","journal-title":"Cancer"},{"key":"BF6603585_CR41","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1136\/gut.35.7.941","volume":"35","author":"PM Sagar","year":"1994","unstructured":"Sagar PM, Gauperaa T, Sue-Ling H, McMahon MJ, Johnston D (1994) An audit of the treatment of cancer of the oesophagus. Gut 35: 941\u2013945","journal-title":"Gut"},{"key":"BF6603585_CR42","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/00000658-200109000-00010","volume":"234","author":"JR Siewert","year":"2001","unstructured":"Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U (2001) Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 234: 360\u2013367, discussion 368\u2013369","journal-title":"Ann Surg"},{"key":"BF6603585_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","volume":"10","author":"R Simon","year":"1989","unstructured":"Simon R (1989) Optimal two-stage designs for phase II clinical trials. Control Clin Trials 10: 1\u201310","journal-title":"Control Clin Trials"},{"key":"BF6603585_CR44","volume-title":"International Union Against Cancer (UICC): TNM Classification of Malignant Tumours","author":"LH Sobin","year":"1997","unstructured":"Sobin LH, Wittekind C (1997) International Union Against Cancer (UICC): TNM Classification of Malignant Tumours. New York: John Willey"},{"key":"BF6603585_CR45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/00000421-200006000-00004","volume":"23","author":"M Stuschke","year":"2000","unstructured":"Stuschke M, Stahl M, Wilke H, Walz M, Oldenburg A, Stuben G, Seeber S, Sack H (2000) Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and midthoracic esophagus. Am J Clin Oncol 23: 233\u2013238","journal-title":"Am J Clin Oncol"},{"key":"BF6603585_CR46","first-page":"1955","volume":"30","author":"T Tanaka","year":"2003","unstructured":"Tanaka T, Sueyoshi S, Sasahara H, Matono S, Yamana H, Shirouzu K, Fujita H (2003) [Preliminary evaluation of chemotherapy with docetaxel, 5-FU, CDDP for recurrent esophageal cancer \u2013 a pilot study]. Gan To Kagaku Ryoho 30: 1955\u20131958","journal-title":"Gan To Kagaku Ryoho"},{"key":"BF6603585_CR47","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0022-5223(97)70085-0","volume":"114","author":"CD Wright","year":"1997","unstructured":"Wright CD, Wain JC, Lynch TJ, Choi NC, Grossbard ML, Carey RW, Moncure AC, Grillo HC, Mathisen DJ (1997) Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: a phase I and II study. J Thorac Cardiovasc Surg 114: 811\u2013815, discussion 816","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6603585.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603585","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603585.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:25:42Z","timestamp":1684412742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6603585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,23]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["BF6603585"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6603585","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,23]]}}}